Skip to main content
logo
Immunotech Biopharm Ltd (HKG:6978)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.3500
-0.0100 (-2.78%)
Nov 3, 2026, 3:59 PM HKT

Immunotech Biopharm Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2161,8091,1842,5732,3838,666
Market Cap Growth
-86.58%52.87%-54.00%7.99%-72.51%50.90%
Enterprise Value
6052,2541,4642,7802,2478,058
Last Close Price
0.362.932.114.604.2615.48

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-77.9877.9877.9877.9877.98
PB Ratio
--94.49-67.6013.674.168.58
P/TBV Ratio
---17.734.528.74

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-4.62-25.59-23.372.680.300.14
Net Debt / Equity Ratio
-3.91-16.60-19.881.640.14-0.29
Net Debt / EBITDA Ratio
-3.07-2.35-2.31-1.57-0.300.75
Net Debt / FCF Ratio
-2.56-2.57-2.14-1.53-0.280.61
Quick Ratio
0.140.320.130.330.381.96
Current Ratio
0.220.350.200.400.572.29
Return on Equity (ROE)
---242.61%-99.07%-48.30%-36.33%
Return on Assets (ROA)
-20.57%-18.75%-17.81%-16.74%-17.34%-18.69%
Return on Capital Employed (ROCE)
-507.30%-156.20%-150.10%-73.10%-40.90%-37.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-94.24%-14.19%-16.81%-14.34%-15.09%-5.02%
FCF Yield
-68.93%-6.85%-13.76%-7.85%-11.82%-5.67%
Buyback Yield / Dilution
-11.58%-2.02%-4.58%---15.95%